Avalo Therapeutics (AVTX) Net Equity Issued and Repurchased (2016 - 2026)
Avalo Therapeutics (AVTX) posted Net Equity Issued and Repurchased of $5.23 million for Q2 2026, compared with $40,000 a year earlier and up 140.2% from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Net Equity Issued and Repurchased (2016 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Avalo Therapeutics was $22.13 million; for FY2025, it was $14.76 million, down 87.2% from FY2024.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -16.1% (FY2020 to FY2025).
- In prior years, Avalo Therapeutics' Net Equity Issued and Repurchased was $115.63 million in FY2024 (+256.1%), $32.47 million in FY2023, $73,000 in FY2022 (-99.7%) and $29.05 million in FY2021 (-18.0%).
- Quarterly Net Equity Issued and Repurchased has run from a low of $40,000 in Q2 2025 to a high of $108.1 million in Q1 2024 over five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Avalo Therapeutics | 386.09 Mn | -587.48 Mn | - | 2.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.54 Mn |
| Jun 30, 2026 | 5.30 Mn |
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 15.52 Mn |
| Jun 30, 2025 | 40,000.00 |
| Dec 31, 2024 | 69.44 Mn |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 25.90 Mn |
| Jun 30, 2023 | 6.60 Mn |
| Mar 31, 2023 | 13.75 Mn |
| Dec 31, 2022 | -14.72 Mn |
| Jun 30, 2022 | 25,000.00 |
| Dec 31, 2021 | 76,000.00 |
| Sep 30, 2021 | 34.36 Mn |
| Jun 30, 2021 | 1.60 Mn |
| Mar 31, 2021 | 37.83 Mn |
| Dec 31, 2020 | 200,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Jun 30, 2020 | 35.58 Mn |
| Mar 31, 2020 | 9.10 Mn |
API Access
Avalo Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();